Skip to main content
Heliyon logoLink to Heliyon
. 2023 Jul 20;9(8):e18492. doi: 10.1016/j.heliyon.2023.e18492

Aromatherapy for the brain: Lavender's healing effect on epilepsy, depression, anxiety, migraine, and Alzheimer's disease: A review article

Nazanin Hatami Bavarsad a, Shokufeh Bagheri a, Masoumeh Kourosh-Arami b, Alireza Komaki a,
PMCID: PMC10404968  PMID: 37554839

Abstract

Neurological diseases affect the nervous system, including the brain, spinal cord, cranial nerves, nerve roots, autonomic nervous system, neuromuscular junctions, and muscles. Herbal medicine has long been used to cure these diseases. One of these plants is lavender, which is composed of various compounds, including terpenes, such as linalool, limonene, triterpenes, linalyl acetate, alcohols, ketones, polyphenols, coumarins, cineole, and flavonoids. In this review, the literature was searched using scientific search engines and databases (Google Scholar, Science Direct, Scopus, and PubMed) for papers published between 1982 and 2020 via keywords, including review, lavender, and neurological disorders. This plant exerts its healing effect on many diseases, such as anxiety and depression through an inhibitory effect on GABA. The anti-inflammatory effects of this plant have also been documented. It improves depression by regulating glutamate receptors and inhibiting calcium channels and serotonergic factors, such as SERT. Its antiepileptic mechanism is due to an increase in the inhibitory effect of GABA and potassium current and a decrease in sodium current. Therefore, many vegetable oils are also used in herbal medicine. In this review, the healing effect of lavender on several neurological disorders, including epilepsy, depression, anxiety, migraine, and Alzheimer’s disease was investigated. All findings strongly support the traditional uses of lavender. More clinical studies are needed to investigate the effect of the plants’ pharmacological active constituents on the treatment of life-threatening diseases in humans. The limitations of this study are the low quality and the limited number of clinical studies. Different administration methods of lavender are one of the limitations of this review.

Keywords: Neurological disorders, Alzheimer’s disease, Lavender, Anxiety, Depression, Epilepsy, Migraine

1. Introduction

Neurological disorders are diseases of the central and peripheral nervous systems. These disorders affect hundreds of millions of people all over the world. More than 50 million people suffer from epilepsy. Globally, there are 47.5 million people with dementia. Dementia is the major cause of Alzheimer's disease (AD) in 7.7 million new cases who develop the disease every year. The prevalence of migraine is more than 10% worldwide [1]. Patients with neurological problems may experience depression or anxiety. Symptoms of these disorders include confusion, paralysis, poor coordination, loss of sensation, seizures, muscle weakness, pain, and altered levels of consciousness. Neurological diseases are treated by the specialties of neurology and clinical neuropsychologists. Several interventions and treatments are considered preventive measures, including lifestyle changes, physiotherapy, neurorehabilitation, pain management, pharmacotherapy, operation, or following a specific diet [2,3]. In 2006, the World Health Organization (WHO), classified these neurological disorders as epilepsy, dementia, migraine, and psychiatric diseases, such as depression and anxiety.

2. Materials and methods

Online databases, including Scopus, ScienceDirect, Google Scholar, and PubMed were assessed for studies published between 1982 and 2020 via keywords, including review, lavender, and neurological disorders. All of the abbreviations are explained in Table 1.

Table 1.

Abbreviations
Alzheimer's disease (AD)
World Health Organization (WHO)
Gamma-aminobutyric acid (GABA-A)
Amyloid precursor protein (APP)
Amyloid β (Aβ)
Acetylcholinesterase inhibitors (AChEIs)
Acetylcholine (ACh)
Transcription factor EB (TFEB)
Generalized anxiety disorder (GAD)
Social anxiety disorder (SAD)
Phobias, posttraumatic stress disorder (PTSD)
Obsessive-compulsive disorder (OCD)
Panic disorder (PD)
Chromogranin A (CgA)
Serotonin reuptake inhibitors (SSRIs)
Serotonin (5-HT)
Voltage gated calcium channels (VGCCs)
Norepinephrine (NE)
Dopamine (DA)
Histamine (H)
Elevated plus-maze (EPM)
Herbal Medicinal Products (HMPC)
Electroconvulsive therapy (ECT)
Major depressive disorder (MDD)
European Medicines Agency (EMA)
Serotonin transporter (SERT)
Tricyclic antidepressants (TCAs)
Anti-epileptic drugs (AEDs)
Pentylenetetrazole (PTZ)
Calcitonin gene-related peptide (CGRP)
Linalyl acetate (LA)
Nitric oxide synthase (NOS)

2.1. Plant description

Lavender is a plant of the mint or Lamiaceae family [4]. This family has different types and species, including Lavandula angustifolia, Lavandula angustifolia, Lavandula hybrida Rev, Melissa officinalis L., Lavandula stoechas, Lavandula latifolia, and Lavandula x intermedia (a cross between L. latifolia and L. angustifolia) [4,5]. Lavender contains 100 different combinations, including terpenes, like linalool, limonene, triterpenes, linalyl acetate, alcohols, ketones, polyphenols, coumarins, cineole, and flavonoids [4] (Fig. 1). L. angustifolia, L. latifolia, and L. Intermedia are used to extract essential oils [6]. Linalool in this plant has an inhibitory effect through gamma-aminobutyric acid (GABA-A) receptors. This effect inhibits the limbic system and reduces anxiety [7,8].

Fig. 1.

Fig. 1

The structure of lavender containing linalool and linalyl acetate. Linalool inhibits gamma-aminobutyric acid (GABA-A) receptors.

Essential oils are abundant and volatile compounds obtained from plant parts, like leaves, seeds, and flowers through different methods, such as distillation [5]. The flowers of this plant are used in decoration in ceremonies and its oil is also used in the cosmetics and perfume industry [9,10]. This plant, especially as an essential oil, has various applications in medicine to treat psychological diseases, such as calming the nervous system, particularly in cases with depression, anxiety, and sleep disorders [11,12]. Its positive effects on the nervous system are related to the impact of its volatile compounds on the hippocampus and amygdala [13].

Aromatherapy using its oil, especially in anxiety and sleep disorders, has been found with very promising results [14]. Lavender has been employed using various methods in different studies, including inhalation, massage therapy, combined massage therapy with aromatherapy, and oral administration [10] (Table 2). It has also been used for the treatment of bloating and for wound healing (as an antibacterial and antifungal agent) and the treatment of insect bites. Lavender has analgesic, anti-inflammatory, and antispasmodic effects, as well [11,12].

Table 2.

The doses, intervention durations, therapeutic response, and mechanism of action of lavender.

Author(s) Study year Study design Treatment Treatment duration Therapeutic response and mechanism of action of lavender Diseases
Lin et al. 2007 Cross-over randomized trial Lavender inhalation
Sunflower inhalation
3 weeks Alleviated agitation in cases with dementia AD
Hancianu et al. 2013 Experimental study Lavender oils 7 days Neuroprotective, antioxidant, and antiapoptotic effects Dementia
Faixova et al. 2008 Clinical study Rosemary oil (Rosmarinus officinalis L., Labiatae, 1 ml) 20 min Relieved depression and stress Depression and stress
Azizi et al. 2012 Experimental study Thymol or carvacrol (0.5, 1, or 2 mg/kg) 14 days Improvement in cognitive impairments by thymol and carvacrol induced by Aβ or cholinergic hypofunction Dementia
Karan NB 2019 Randomized clinical trial Lavender oil 3 min Lavender oil has strong anxiolytic effects Anxiety
Komaki et al. 2014 Experimental study Linalyl acetate (50 and 100 mg/kg) 30 min Anti-anxiety effects via modulating voltage-dependent calcium channels and glutamatergic transmission Anxiety
Schuwald et al. 2013 Clinical trial Silexan (1 and 30 mg/kg/day), 0.2% agar suspension (10 ml/kg), diazepam (2.5 mg/kg), or pregabalin (100 mg/kg) 3 days Anxiolytic effects by modulating voltage-dependent calcium channels Anxiety
Ebrahimi et al. 2022 Clinical trial Lavender and chamomile essential oils 30 days Decreased depression, anxiety, and stress Anxiety and Depression
Xiong et al. 2017 Clinical trial 50 μL of lavender [Lavandula angustifolia], sweet orange [Citrus sinensis], and bergamot (Citrus bergamia) oils 8 weeks Decreased depression by an aromatherapy massage and aromatherapy inhalation Depression
Linck et al. 2010 Experimental study Linalool and Diazepam (0.5 and 1.0 mg/kg) 60 min Anxiolytic effects increased social interaction and decreased aggressive behavior in rats Anxiety
de Almeida et al. 2012 Experimental study Limonene epoxide at the doses of 25, 50, and 75 mg/kg (i.p.) 14 days Anxiolytic-like effect on mice Anxiety
Effati-Daryani et al. 2015 Randomized placebo-controlled trial Lavender cream 8 weeks Reduction in anxiety, stress, and depression Anxiety and Depression
Tayebi et al. 2015 Clinical trial Lavender essential oil 4 weeks The scores of depression and stress significantly decreased but this reduction was not significant for anxiety scores. Anxiety and Depression
Bazrafshan et al. 2020 Randomized clinical trial Inhaled lavender 4 weeks Reduction in anxiety-depression score
Blockage of the serotonin transporter (SERT) and antagonism effects on the N-methyl-d-aspartate receptors (NMDA receptors)
Anxiety and Depression
Shin et al. 2018 Experimental study Linalyl acetate (10 or 100 mg/kg) or metformin (500 mg/kg) 7 days Linalyl acetate can be efficient in diabetic patients with cardiovascular disease or chronic stress
LA restored serum nitrite levels, acetylcholine-induced vasorelaxation, blood pressure, heart rate, and AMP-activated protein kinase
Chronic stress
Zamanifar et al. 2020 Randomized controlled clinical trial 1.5% chamomile-lavender 20 min Reduced anxiety of nurses in the clinical setting Anxiety
Karimzadeh et al. 2021 Randomized controlled clinical trial 5 drops of lavender 30 min Improved the state of anxiety and agitation management in the ICU setting Anxiety
Emami-Moghadam et al. 2022 Randomized controlled clinical trial Lavender 30 min Reduced ECT-related anxiety in depressed patients Anxiety
Araj-Khodaei et al. 2020 Randomized controlled clinical trial L. angustifolia (2 g) or fluoxetine (20 mg) 8 weeks Anti-depressant effect Depression
Firoozeei et al. 2020 Randomized controlled clinical trial Lavender-dodder herbal syrup (5 ml) 3 weeks Treated major depressive disorder with anxious distress Depression
Chen et al. 2021 Randomized controlled clinical trial 100% Lavandula angustifolia (0.1 ml) + 100% Citrus bergamia (0.1 ml) 28 days Improved headache-related quality of life among nurses working in the emergency and critical care units Migraine
Rakotosaona et al. 2016 Experimental study C. madagascariensis (CMEO)- (0.4 and 0.8 ml/kg bw) 4 weeks Anticonvulsant effects Epilepsy
Rafie et al. 2016 Randomized controlled clinical trial Lavender 3 months Reduction in frequency and severity of migraine Migraine

3. The effects of lavender on neurological/neuronal disorders

3.1. Lavender and Alzheimer’s disease (AD)

AD is a neurodegenerative multifarious disease [15]. It is the most common neurodegenerative disease [5]. The combination of genetic and environmental factors plays a role in the development of AD. It has familial and sporadic types and there is early- or late-onset AD [16,17]. Mutation in specific genes, such as presenilin I and II, amyloid precursor protein (APP), and apolipoprotein E is associated with the pathophysiology of this disorder [18]. Dementia is observed in 5% of people over the age of 65 and most dementia patients have psychological and behavioral symptoms [19]. AD as a cognitive disorder is the most common form of dementia and accounts for 2% of its types. Several hypotheses, such as senile plaques and neurofibrillary tangles have been suggested as the pathobiology of the disorder. The plaques are formed from amyloid-β (Aβ) peptides, and neurofibrillary tangles are created from hyper-phosphorylated tau proteins [20,21]. There are several other theories, like the cholinergic hypothesis, oxidative stress hypothesis, mitochondrial cascade hypothesis, and inflammation hypothesis. When the balance between oxidants and antioxidants is disturbed, free radicals are produced that damage neurons. The accumulation of α-synuclein and neurodegenerative progression is guided by the proinflammation stage. Besides, a few viruses may have a role as stimulators and generate a cross-autoimmune response for α-synuclein [22]. Cholinesterase inhibitor prevents the breakdown of acetylcholine (ACh), which is an important neurotransmitter in memory [23]. Acetylcholinesterase inhibitors (AChEIs) having antioxidant potential can enhance learning and memory [24]. Piperazine-tethered biphenyl-3-oxo-1,2,4-triazine derivatives were synthesized as a non-competitive acetylcholinesterase inhibitor [25]. During the process of aerobic respiration, radicals are produced and attack the cell. Oxidative stress plays a very important role in the pathobiology of AD. Increasing age and AD cause an increase in the production of free radicals, which leads to subsequent oxidative damage. Another molecular target, namely transcription factor EB (TFEB), has been explored globally to treat neurodegenerative disorders. This TFEB is a key regulator of autophagy and the lysosomal biogenesis pathway [26]. Herbal remedies play a crucial role in the progression of medicine, and many advanced drugs have already been developed. Many studies have endorsed practicing herbal remedies with phytoconstituents for healing AD [27]. Essential oils rich in antioxidants fight free radicals that cause oxidative stress [23,[28], [29], [30]]. Licensed and marketed drugs for AD include cholinesterase inhibitors, like rivastigmine, galantamine, and donepezil. Also, N-AChE was the first drug approved in 1993; however, its use was discontinued due to many side effects [31,32]. Essential oils of vegetables affect brain function due to crossing the blood-brain barrier [23]. The aroma of vegetable oils used through inhalation or massage affects the limbic system after penetrating into the blood system [33].

Essential oils used through inhalation or massage directly affect cognition, but most human and animal studies have preferred the inhalation method to study AD. Oils entering the blood probably reach the limbic system through the nose and lung mucus and affect the olfactory nerve [33]. The effect of essential oils is related to the cholinergic hypothesis and oxidative stress hypothesis. A decrease in Ach and the loss of cholinergic neurons impair cognitive function and memory. The oxidative stress hypothesis is related to the factors causing AD, such as Aβ-induced neuronal loss, tau protein pathology, mitochondria dysfunction, and disturbance in metal homeostasis [[34], [35], [36]]. Essential vegetable oils have received considerable attention due to their antioxidant and anti-amyloid, and cholinesterase inhibitory properties [37] (Fig. 2). In 2007, Lin et al. showed the effect of essential oils obtained from L. angustifolia on agitation in patients with dementia and AD [38]. Hancianu et al. in 2013 assessed the effect of L. angustifolia, L. Angustifolia Mill., and hybrid lavender and showed their significant antioxidant and antiapoptotic potentials and their ability to increase the level of immune system antioxidant enzymes in scopolamine-induced dementia rat models [39]. Also, it has been shown that essential oils of L. angustifolia Mill. has a long-term effect on attention [40]. Rosmarinus officinalis L. has strong antioxidant compounds that reduce oxidative stress as one of the causes of AD [5] (Fig. 2). The combination of essential oils derived from R. officinalis can improve memory in dogs and rats [41]. M. officinalis L. is also a strong antioxidant and reduces oxidative stress and protects the brain against oxidative damage [23,42]. Essential oils obtained from L. angustifolia are rich in thymol. Azizi et al. demonstrated that different doses of thymol or carvacrol (0.5, 1, or 2 mg/kg) can improve cognitive function in animals with impaired memory induced by the injection of scopolamine and Ab25–35 peptide. The beneficial effects observed in these models may be due to the anticholinesterase, antioxidant, and anti-inflammatory activities of thymol and carvacrol [43,44]. The antioxidant and antiapoptotic effect of L. angustifolia, L. Angustifolia Mill., and hybrid lavender has been reported in scopolamine-induced dementia in rats. Essential oils obtained from L. angustifolia and R. officinalis improved cognitive functions and memory in animal models.

Fig. 2.

Fig. 2

Pathophysiology of Alzheimer's Disease (AD); antioxidant, anti-inflammatory, and anti-cholinergic effects of essential oils.

3.2. Lavender and anxiety

Anxiety is one of the psychiatric disorders and women are nearly twice as likely to experience anxiety as men [45]. This disorder is associated with excessive fear related to acute dysfunction of the autonomic system and behavioral disturbance [46]. It triggers the release of hormones, such as cortisol, noradrenaline, and adrenaline by affecting the sympathetic nervous system [47]. Anxiety is a vague, unpleasant, and diffuse feeling of anxiety associated with physical symptoms, such as sweating and high blood pressure [48]. About 4% of the world's population has one or more than one anxiety disorders [49]. The prevalence of fear and anxiety in western societies is about 20–30%. The disease imposes a significant economic burden on society [50].

Different types of anxiety disorders are generalized anxiety disorder (GAD), social anxiety disorder (SAD), phobias, posttraumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and panic disorder (PD) [50]. In addition to blood pressure and heart rate, stress markers, including cortisol and salivary chromogranin A (CgA), are used to assess anxiety [51]. Anxiety is treated with psychotherapy and medication but patients with more severe anxiety disorders may develop depression and physical illnesses and are prone to substance abuse [52]. Anxiety medications, such as benzodiazepines and selective serotonin reuptake inhibitors (SSRIs) have side effects, like amnesia, sedation, and diminished concentration [53]. Therefore, there is a need for more effective drugs with fewer side effects [54]. Also, even patients using drugs, psychotherapy, and brain stimulation therapies show little or no improvement, which indicates the need for newer methods to treat this disorder [50,55,56].

Based on studies performed on normal people and people with anxiety, some chemicals and neurotransmitters have been shown to be involved in anxiety [57]. Neurotransmitters involved in this disorder include serotonin (5-HT), norepinephrine (NE), GABA, dopamine (DA), histamine (H), and Ach [57,58]. The sedative effects of lavender oil inhalation have been extensively studied on animals [7]. The acute effects of hydro-alcoholic extract of lavender (25, 50, or 100 mg/kg, intraperitoneally) on anxiety-like behavior in rats were demonstrated using an elevated plus-maze (EPM) test. Lavender extract showed an anxiolytic effect similar to that of low-dose diazepam [59]. Various studies have shown the effect of lavender oil in the form of creams and perfumes on the treatment of anxiety and its effect on anxiety is similar to chlordiazepoxide and is more effective than lorazepam [60]. In different studies, the positive effects of lavender using various methods, such as massage and inhalation during labor, have been shown [61]. Siloxane is a standardized form of lavender essential oil collected from the distillation of the fresh L. angustifolia Miller flowers [62]. Silexan acts through the potent inhibition of voltage-dependent calcium channels in brain areas, such as the hippocampal neurons [63]. The Committee on Herbal Medicinal Products (HMPC) of the European Medicines Agency (EMA) has accepted the use of oral lavender essential oil for the treatment of mental stress, and it is licensed in 14 countries around the world. Lavender oil has been shown to inhibit voltage-dependent calcium channels (VOCCs) in synaptosomes, primary hippocampal neurons, and stably overexpressing cell lines in a similar range as pregabalin. This inhibition is mainly mediated via N-type and P/Q-type VOCCs. However, further investigations are needed to assess the long-term effects of lavender use [4,64]. Lavender is one of the most effective and healthy choices for treating anxiety [8]. Essential oils of lavender increased happiness hormones even by ten times [65].

L. angustifolia (also named L. vera or L. officinalis), which is the most widely used species of lavender, has important compounds, including linalyl acetate and linalool. These compounds are responsible for the medicinal effects of the plant, including its sedative effects [4]. Linalool in lavender has an inhibitory effect on the GABA-A receptors, and autonomic and limbic systems that lower blood pressure [7,63].

Lavender essential oils exert their calming effect through various proposed mechanisms, such as GABA receptor inhibition, the reaction of linalool with glutamatergic NMDA receptors, inhibition of serotonin transporter (SERT), antagonizing the NMDA receptor, inhibiting tension-dependent calcium channels, and affecting the 5HT-1A receptor in specific brain areas, such as temporal gyrus [4,64,[66], [67], [68]]. The results of a study showed that the interventions using music therapy and aromatherapy with chamomile-lavender essential oil could reduce the anxiety of nurses in clinical settings [69]. In 2021, the positive effects of lavender aromatherapy and Citrus aurantium aromatherapy on reducing the anxiety of patients were documented [70]. Inhalation with 1.5% lavender and chamomile essential oils for 30 nights decreased depression, anxiety, and stress levels in community-dwelling older adults [71]. Aromatherapy with inhaled lavender essential oil and breathing exercises can be considered an effective intervention to reduce electroconvulsive therapy (ECT)-related anxiety in depressed patients [72]. Aromatherapy with lavender treated anxiety and depression in patients. This herb has a sedative effect through the inhibition of GABA receptor, inhibition of SERT, antagonizing the NMDA receptors, inhibition of tension-dependent calcium channels, and affecting the 5HT-1A receptors in specific brain areas, such as temporal gyrus.

3.3. Lavender and depression

Depressive disorder is one of the cognitive disorders [73]. Depression is a major mental health problem in the world, affecting more than 350 million people [74]. In most cases, depression is the result of or associated with chronic illnesses or mood disorders [75]. Decreased concentration, anxiety, low mood, and anhedonia are some of the symptoms of this disorder [76].

The most important type of depression is major depression, which has symptoms, like insomnia, fatigue, the lack of pleasure, feeling guilty, suicidal thoughts or attempts to suicide, weight loss, or loss of appetite. Tricyclic antidepressants (TCAs), like imipramine and amitriptyline, are still prescribed to treat depression. One of the most common antidepressants is fluoxetine as an SSRI [77]. Trazodone and amoxapine are also used for the treatment of this disorder [78]. Nearly 50% of depressed patients respond positively to pharmacological treatment [79]. It has recently been shown that exercise as a non-pharmacological method is effective in the treatment of this disorder [80]. Aromatherapy by massage and inhalation can alleviate the symptoms of depression [81].

Depression is one of the most common emotional problems, especially in women. Because of the side effects of antidepressants, the use of alternative and complementary therapies has been considered [82,83]. Different psychotherapeutic approaches are used to treat depression, which are not followed by the patient because they are time-consuming and costly [[84], [85], [86]]. Although drugs, like SSRI, are effective in treating depression, they are associated with side effects, like developing neuropsychiatric conditions, such as sleep disorders and sexual dysfunction. Thus, there is a need to develop new treatments, especially for prevention and the treatment of a milder type of disorder [87,88]. Aromatherapy is effective in improving mental and physical function [89]. Also, this method has few side effects and is not expensive [90]. Aromatherapy has been reported to be effective in reducing depression in postmenopausal women, cases with major depressive disorder (MDD), postpartum women, and patients with cancer [81]. In a test conducted in 2014, it was found that aromatherapy can be effective in relieving depression, pain, and stress in adults [91]. In Europe, lavender oil is traditionally used to reduce stress and anxiety [88]. One of the best-selling herbal oils for depression is lavender essential oils [92]. Monoterpenes, such as linalool and linalyl acetate in lavender essential oil, are responsible for its anti-depressant properties [93,94].

The antidepressant effect of lavender is related to its effect on the modulation of glutamate NMDA-receptor and SERT [88]. Linalool in lavender can react with the glutaminergic system and NMDA receptors [95,96] (Fig. 3). The hydroxyl group of linalool also appears to be responsible for its effect on the serotonin transporter (SERT). Administration of a mixture of cis and trans (+)-limonene epoxide has been shown to exert an anxiolytic-like effect in mice. In the open field test, intraperitoneal administration of (+)-limonene epoxide at doses of 25, 50, and 75 mg/kg significantly reduced the number of crossings, grooming, and rearing [97].

Fig. 3.

Fig. 3

Aromatherapy by lavender treats depression by inhibiting voltage-dependent calcium channels and serotonergic factors and modulating NMDA receptors.

In a study in 2013, it was found that the essential oils of this plant can inhibit voltage-dependent calcium channels in brain areas, such as primary hippocampal neurons [94]. Essential oils of the plants, such as lavender, inhibit serotonergic factors, like SERT, which indicates their antidepressant effects. In a study, M. officinalis (2 g), L. angustifolia (2 g), or fluoxetine (20 mg) were administered to participants, and their effects were assessed in weeks 0, 2, 4, and 8 using the Hamilton Rating Scale for Depression (HAM-D). Both M. officinalis and L. angustifolia showed similar effects to fluoxetine in treating mild to moderate depression [98,99] (Fig. 3). Also, L. angustiifolia has antidepressant, sedative, and antidepressant effects because of the compounds, such as linalool, linalyl acetate, flavonoid, local anesthetic tannins, ocimene, caryophyllene oxide, and coumarin [[100], [101], [102], [103]]. Lavender with compounds, such as linalool and linalyl acetate was effective in improving mood in pregnant women used by inhalation in a short period of time [104]. The therapeutic effects of lavender cream, either used with foot-bath or alone (2 g applied every night for two months), on the mental health of pregnant women with depression and stress have been reported [105]. Also, its therapeutic effects on hemodialysis patients suffering from stress and depression have been shown [106]. In a study conducted in 2020 in Iran, the mean score of depression and anxiety in the lavender group showed a decrease compared with the controls [107]. The consumption of lavender herbal tea has been shown to reduce depression and anxiety scores [108]. Additionally, taking 5 mL of lavender-dodder herbal syrup every 12 h has been found to be an effective and well-tolerated supplement for treating major depressive disorder (MDD) with anxious distress [109]. In a similar clinical trial on the effect of inhalation of lavender, aromatherapy with lavender essential oils decreased stress, depression, and anxiety in older adults compared to the control group [71].

Aromatherapy is effective in reducing depression in postmenopausal women, cases with major depressive disorder, postpartum women, and patients with cancer. Lavender can modulate the glutaminergic system and NMDA receptors.

3.4. Effect of lavender oil on epilepsy

Approximately 20–30% of patients with epilepsy have drug-resistant seizures [110,111]. Also, seizure recurrence is observed in 5% of people worldwide, and 35% of people have uncontrolled epilepsy [112]. Proper diagnosis of epilepsy syndrome is essential, and when refractory epilepsy is confirmed, surgery is regarded for patients [[113], [114], [115]]. Surgery is used selectively for patients with treatment-resistant focal seizures [116,117]. Other treatments for epilepsy are underused vagal nerve stimulation [112] or closed-loop cortical stimulation [118]. New-generation anti-epileptic drugs (AEDs) have side effects, including psychological complications, like depression, anxiety, and cognitive deficits [110]. However, these AEDs have fewer side effects in comparison with older-generation AEDs [119]. Natural products used in traditional medicine are powerful sources of new AEDs. They have been primary treatments for patients with epilepsy because of their availability. Also, Ekstein in 2010, confirmed that new drug therapies are more cost-effective for patients [119]. Lifestyle changes can prevent seizure precipitation in teenagers with idiopathic generalized epilepsy [112]. Strong anticonvulsive effects of lavender and other essential oils high in linalool have been demonstrated in animal models of seizure [120]. Linalool is known as a monoterpene alcohol that strengthens GABAA function in mammalian electrophysiology experiments [121]. Linalool oxide, linalyl acetate, 8-oxo linalyl acetate, 8-carboxy linalyl acetate, and 8-oxo linalool are linalool derivatives and metabolites. Also, these metabolites play a role in GABA-A function [121,122]. In snail neurons, linalool inhibits sodium channels and increases potassium currents (Fig. 4). The lower concentration of linalool has a suppressive effect on spontaneous activity and PTZ-induced epileptiform activity. A higher concentration of linalool can induce epileptiform activities, reversible by calcium channel blockers [123]. The administration of Cinnamosma madagascariensis (0.4 and 0.8 mL/kg bw), Zhumeria majdae, and Citrus aurantium blossom oils has been found to decrease convulsions in animals treated with PTZ. Furthermore, these oils have been shown to increase latency and survival [[124], [125], [126]]. Inhaled lavender essential oil (1 mL) administrated 15 min before pentylenetetrazole (PTZ) treatment, could prevent all convulsions in 100% of the animals leading to a 100% survival rate. The animals of the control group receiving PTZ were found with seizures and at this dose, there was a 100% mortality rate [127]. Lavender increases GABAA function and potassium current. Inhaled lavender essential oil before PTZ treatment could prevent all convulsions in animals.

Fig. 4.

Fig. 4

Lavender exerts antiepileptic effects by increasing potassium current and GABA function and reducing sodium current.

3.5. Effect of lavender on migraine

Migraine is a chronic disease and according to the World Health Organization, it is the sixth most disabling disease worldwide among all neurological disorders (G. B. D. Neurological Disorders Collaborator Group, 2017). It has been reported that 17% of women and 6% of men have migraine [128]. Nausea, vomiting, and sensitivity to light and sound are some of its symptoms. Migraine headaches with moderate to severe intensity, start on one side of the head. They occur through hypothalamic disturbance that changes blood flow through intra- and extra-cranial blood vessels by a trigeminovascular reflex [129,130]. Different mental, environmental, and genetic factors are involved in the development of the disease [131,132]. In China, the prevalence rate of migraine was about 9.3% in 2012 [132]. This neurological disorder is associated with hormonal changes. After puberty, the incidence of migraine increases, whereas its prevalence decreases during pregnancy [133,134]. There is an increase in plasma levels of calcitonin gene-related peptide (CGRP), a strong vasodilator and marker of trigeminal inflammation, in patients with migraine [135]. Different factors, like nutritional habits, hormonal diseases, digestive disorders, autoimmune disorders, structural imbalances, mental stress, and lifestyle are involved in the pathology of migraine [136]. Venlafaxine, beta-blockers, valproate, topiramate, amitriptyline, flunarizine, magnesium, gabapentin, and botulinum toxin type A are used to treat migraine [137]. The headache frequency and severity are prevented by supplements and medicinal herbs [138,139]. The effectiveness of traditional medicine and medicinal herbs has been demonstrated worldwide [140]. Pharmacotherapy, massage therapy, acupuncture therapy, and aromatherapy are used for the treatment of migraine. The best treatment for relieving the symptoms of the disease is aromatherapy. Traditional Chinese Medicine Aromatherapy is a monograph that indicates the efficacy of aromatic plants and their application in the treatment of different diseases [141]. Based on a single-blind study assessing the effectiveness of the topical usage of lavender oil on migraine, 47 patients with migraine at the beginning of attacks, were administrated with two to three drops of a placebo solution (liquid paraffin) or lavender oil rubbed onto their upper lip followed by inhalation the vapor for 15 min [142]. The procedure was employed for six consecutive migraine attacks. According to the results obtained from the 129 migraine attacks through the research period, the lavender group had a 3.6-point decrease in rating severity (on a 10-point rating scale), which was significantly more compared to the 1.6-point decrease in rating severity in the placebo group (obtained data from 68 attacks). The lavender group (71%) also showed a higher percentage of total or partial responders than the placebo group (47%). In addition, 74% of the subjects in the lavender group showed an improvement in migraine symptoms (vomiting, nausea, photophobia, and phonophobia) in comparison with only 58% in the placebo group. In animal models, lavender caused a reduction in inflammation and neuropathic pain by affecting peripheral and central opioid and cannabinoid 2 receptors [143]. In another animal research, after renal ischemia/reperfusion injury, lavender oil significantly improved antioxidant enzyme activity, decreased lipid peroxidation, and markedly reduced concentration of the cytokines, tumor necrosis factor-α, and interleukin-1β [144]. Also, the effect of lavender as a prophylactic therapy was investigetad for migraine in a randomized controlled clinical trial. In a three-month trial, the group that received lavender showed a decrease in the frequency and severity of migraine attacks. Additionally, lavender oil was found to be effective in preventing migraines [140]. Studies on human cell lines have indicated the efficacy of estrogenic and antiandrogenic properties of the lavender oil and it can be used in adults with an obvious allergy to lavender [145].

Linalyl acetate (LA), available in lavender oil, exerts its anti-inflammatory effects by inhibiting the NF-κB activation. According to the results reported by Koto et al. (2006), rabbit carotid arteries were dilated by lavender [146]. Arginine nitrate, as a nitric oxide synthase (NOS) inhibitor, and 1H-[1,2,4] oxadiazole [4,3-α] quinoxaline-1-one, as the guanylyl cyclase inhibitor, have relaxation effects [141]. Shin et al. (2018) also found that in diabetic rats, the isolated aortic vasodilation caused by stress from ACh increased following an intraperitoneal injection of a low concentration of LA [147] (Fig. 5). In addition, by an increase in the concentration of LA, ACh-related vasodilation approximately reached the control levels. Accordingly, LA may have an anti-migraine effect via inhibiting neurogenic inflammation and balancing vasomotor impairments. Therefore, more studies on plant essential oils are needed to develop novel anti-migraine agents [141]. A study found that using a 1:1 combination of essential oils from Lavandula angustifolia and Citrus bergamia (0.1 mL of 100% Lavandula angustifolia +0.1 mL of 100% Citrus bergamia) for 28 days effectively improved the quality of life, particularly among nurses working in emergency and critical care units during the intervention period [148]. Lavender oil significantly improved antioxidant enzyme activity, reduced lipid peroxidation, decreased the concentration of the cytokines, tumor necrosis factor-α, and interleukin-1β, and improved migraine in human, animal, and cell studies.

Fig. 5.

Fig. 5

Linalyl acetate (LA) in lavender oil exerts anti-migraine effects due to its anti-inflammatory effect. Also, isolated aortic vasodilation is caused by LA.

4. Summary

Lavender has several therapeutic effects, ranging from inducing relaxation to treating parasitic infections, burns, insect bites, and spasms. There is growing evidence suggesting that lavender oil may be an effective medicament in the treatment of several neurological disorders. Several animal and human investigations have reported the anxiolytic, mood stabilizer, sedative, analgesic, anticonvulsive, and neuroprotective properties of lavender. These studies raised the possibility of the revival of lavender's therapeutic efficacy in neurological disorders. In this paper, we reviewed the current experimental and clinical state of knowledge about the effect of lavender on the nervous system [149]. Lavender is effective on neurodegenerative diseases [150]. There is some evidence to suggest that lavender may have a beneficial effect on neurodegenerative diseases such Alzheimer's disease (Fig. 6). Although there is considerable debate as to whether lavender species have the significant clinical potential either alone or as an adjunct to other substances, many human studies support its effectiveness in different neurological and psychological disorders. Lavender was used predominantly by oral administration, aromatherapy, or massage in several clinical studies with several advantages. In addition to psychological effects, aromatherapy is thought to be therapeutically effective due to the physiological effects of inhaled volatile compounds. It is believed that inhaled lavender acts on the limbic system, particularly the amygdala, and hippocampus [151]. Linalool and linalyl acetate are rapidly absorbed through the skin after topical application with massage and can cause central nervous system depression [152].

Fig. 6.

Fig. 6

Lavender may have a beneficial effect on neurodegenerative diseases such Alzheimer's disease.

The recent rise in popularity of alternative medicine and natural products has increased interest in lavender and its essential oils as potential natural remedies [153]. This review may be useful in increasing our knowledge of lavender's pharmacological effects and improving our future experimental and clinical research plans. Although lavender may have a significant clinical potential either alone or as adjuvant therapy in different disorders, due to some issues, such as methodological inadequacies, small sample sizes, short duration of lavender application, lack of information regarding appropriate dose, variation between efficacy and effectiveness in trials, variability of administration methods, the absence of a placebo comparator, or the lack of control groups in the conducted studies, more standard experiments and studies are needed to confirm the beneficial effect of lavender on the neurological disorders [154]. Methodological and oil identification problems have also hampered the evaluation of the therapeutic significance of some research on lavender. The dried lavender flowers used in some trials were sourced from a local herb store [155]. Although taxonomic identification was confirmed in these studies [156], without quantification of key constituents, the quality of the herbal product may be questionable. Although some studies have defined the contents of lavender, it is imperative that all future clinical studies specify the exact derivatives of the oils used in the study and preferably include the liquid profile or percentage of the main constituents. In addition, several factors, such as temperature, skin type and quality, and the size of the area being treated, which may affect the level and rate of lavender absorption after massage or aromatherapy, have not been considered in several investigations. Many discreet compounds in lavender oil have shown a myriad of potential therapeutic effects, and researchers are still looking for new treatments for various diseases [153]. Lavender has healing effects through inhibitory effects on GABA. The anti-inflammatory effects of this plant have also been proven. It improves depression by regulating glutamate receptors and inhibiting calcium channels and serotonergic factors, such as SERT. Its antiepileptic mechanism is due to an increase in the inhibitory effect of GABA and potassium current and a decrease in sodium current.

Several animal experiments have suggested the anxiolytic, sedative, analgesic, anticonvulsive, and neuroprotective properties of lavender [157]. Lavender possesses an anticonflict effect in mice [158]. Essential oils obtained from L. angustifolia and R. officinalis improved cognitive functions and memory in animal models. Lavender oil improved antioxidant enzyme activity, reduced lipid peroxidation, markedly decreased the concentration of the cytokines, tumor necrosis factor-α, and interleukin-1β, and improved migraine in human, animal, and cell studies.

4.1. Safety

Lavender is probably safe to consume in the amounts commonly used in foods. Short-term oral intake in the amounts tested in lavender studies on anxiety or other conditions may also be safe. The topical use of products containing lavender may cause allergic skin reactions in some people. A few cases of swelling of breast tissue have been reported in children who used topical products containing lavender. However, it is unclear whether the lavender was responsible for breast swelling, a condition that can have many causes. Little is known about the safety of using lavender during pregnancy or while breastfeeding.

5. Conclusion

Published reports clearly have suggested that lavender is an important medicinal plant in traditional medicine. The presence of various compounds, including terpenes, such as linalool, limonene, triterpenes, linalyl acetate, alcohols, ketones, polyphenols, coumarins, cineole, flavonoids, vitamins, and some trace metals are also reported in the seeds of this plant, which add value to its medicinal properties. In conclusion, all these findings strongly support the traditional uses of lavender. More clinical studies are needed to investigate the effectiveness of the plans’ pharmacological active constituents to overcome life-threatening diseases, such as several neurological disorders, including epilepsy, depression, anxiety, migraine, and AD as known diseases of the central and peripheral nervous systems.

6. Limitations and futures

The most important limitation of this review is the low average quality of available studies on the topic. The majority of included RCTs were characterized by a high overall risk of bias. Another limitation is the heterogeneity of study designs, especially in non-oral ways of administration. Overall, oral administration of lavender essential oil is effective in the treatment of anxiety, whereas, regarding inhalation, there is only an indication of a reasonable effect, due to the heterogeneity of available studies. Lavender essential oil administered through massage appears effective, but available studies are not sufficient to determine whether this effectiveness is due to a specific effect of lavender. Further high-quality RCTs with more homogeneous study designs are needed to confirm these findings. Available information outlines a safe profile for lavender-based interventions, although more attention should be paid to the collection and reporting of safety data in future studies. Considering these findings, as treatments with lavender essential oil generally seem safe, and, in the case of inhalation, also simple and inexpensive, they are a therapeutic option, which may be considered in some clinical settings. The production of essential oil-based medicines as multi-potent targets is felt highly. Although no side effects have been reported about aromatherapy with lavender on some disorders, more attention should be paid to adverse effects by allergists and healthcare providers. Robust study design, longer follow-up, and larger sample sizes in various studies should be considered in future investigations.

Author contribution statement

All authors listed have significantly contributed to the development and the writing of this article. All authors read and approved the final manuscript.

Funding statement

The current study was funded (Grant No.: IR.UMSHA.REC.1400.771) by Hamadan University of Medical Sciences, Hamadan, Iran.

Declaration of competing interest

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

Alireza Komaki reports was provided by Hamadan University of Medical Sciences. Alireza Komaki reports a relationship with Hamadan University of Medical Sciences that includes: employment.

Acknowledgments

The authors are grateful to the staff of the Neurophysiology Research Center, Hamadan University of Medical Sciences for supporting this study.

References

  • 1.Organization WH, eHealth WHOGOf, eHealth WGOf . 2006. Building Foundations for eHealth: Progress of Member States: Report of the WHO Global Observatory for eHealth: World Health Organization. [Google Scholar]
  • 2.Patel V., Chisholm D., Dua T., Laxminarayan R., Medina-Mora M.E. The International Bank for Reconstruction and Development/The World Bank. vol. 4. 2016. Alcohol use and alcohol use disorders--mental, neurological, and substance use disorders: disease control priorities. [PubMed] [Google Scholar]
  • 3.Zis P., Hadjivassiliou M. Treatment of neurological manifestations of gluten sensitivity and coeliac disease. Curr. Treat. Options Neurol. 2019;21(3):10. doi: 10.1007/s11940-019-0552-7. [DOI] [PubMed] [Google Scholar]
  • 4.Donelli D., Antonelli M., Bellinazzi C., Gensini G.F., Firenzuoli F. Effects of lavender on anxiety: a systematic review and meta-analysis. Phytomedicine. 2019;65 doi: 10.1016/j.phymed.2019.153099. [DOI] [PubMed] [Google Scholar]
  • 5.Ayaz M., Sadiq A., Junaid M., Ullah F., Subhan F., Ahmed J. Neuroprotective and anti-aging potentials of essential oils from aromatic and medicinal plants. Front. Aging Neurosci. 2017;9:168. doi: 10.3389/fnagi.2017.00168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bienvenu F. 1995. Lavender Growing for Oil Production: Department of Primary Industries. [Google Scholar]
  • 7.Karan N.B. Influence of lavender oil inhalation on vital signs and anxiety: a randomized clinical trial. Physiol. Behav. 2019;211 doi: 10.1016/j.physbeh.2019.112676. [DOI] [PubMed] [Google Scholar]
  • 8.Babaev O., Chatain C.P., Krueger-Burg D. Inhibition in the amygdala anxiety circuitry. Exp. Mol. Med. 2018;50(4):1–16. doi: 10.1038/s12276-018-0063-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Krau S.D. Elsevier Health Sciences; E-Book: 2020. Complementary and Alternative Medicine, Part I: Therapies, an Issue of Nursing Clinics. [Google Scholar]
  • 10.Sayed A.M., Morsy S., Tawfik G.M., Naveed S., Minh-Duc N.T., Hieu T.H., et al. The best route of administration of lavender for anxiety: a systematic review and network meta-analysis. Gen. Hosp. Psychiatr. 2020;64:33–40. doi: 10.1016/j.genhosppsych.2020.02.001. [DOI] [PubMed] [Google Scholar]
  • 11.Farrar A.J., Farrar F.C. 2020. Clinical Aromatherapy. The Nursing Clinics of North America. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Özkaraman A., Dügüm Ö., Yılmaz H.Ö., Yeçilbalkan Ö.U. Aromatherapy: the effect of lavender on anxiety and sleep quality in patients treated with chemotherapy. Clin. J. Oncol. Nurs. 2018;22(2) doi: 10.1188/18.CJON.203-210. [DOI] [PubMed] [Google Scholar]
  • 13.Heuberger E., Redhammer S., Buchbauer G. Transdermal absorption of (−)-linalool induces autonomic deactivation but has no impact on ratings of well-being in humans. Neuropsychopharmacology. 2004;29(10):1925–1932. doi: 10.1038/sj.npp.1300521. [DOI] [PubMed] [Google Scholar]
  • 14.Sentürk A., Kartin P.T. The effect of lavender oil application via inhalation pathway on hemodialysis patients' anxiety level and sleep quality. Holist. Nurs. Pract. 2018;32(6):324–335. doi: 10.1097/HNP.0000000000000292. [DOI] [PubMed] [Google Scholar]
  • 15.Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat. Rev. Mol. Cell Biol. 2007;8(2):101–112. doi: 10.1038/nrm2101. [DOI] [PubMed] [Google Scholar]
  • 16.Bertram L., Lill C.M., Tanzi R.E. The genetics of Alzheimer disease: back to the future. Neuron. 2010;68(2):270–281. doi: 10.1016/j.neuron.2010.10.013. [DOI] [PubMed] [Google Scholar]
  • 17.Tanzi R.E. A brief history of Alzheimer's disease gene discovery. J. Alzheim. Dis. 2013;33(s1):S5–S13. doi: 10.3233/JAD-2012-129044. [DOI] [PubMed] [Google Scholar]
  • 18.Giri M., Zhang M., Lü Y. Genes associated with Alzheimer’s disease: an overview and current status. Clin. Interv. Aging. 2016;11:665. doi: 10.2147/CIA.S105769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Aalten P., de Vugt M.E., Lousberg R., Korten E., Jaspers N., Senden B., et al. Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory. Dement. Geriatr. Cognit. Disord. 2003;15(2):99–105. doi: 10.1159/000067972. [DOI] [PubMed] [Google Scholar]
  • 20.Mohandas E., Rajmohan V., Raghunath B. Neurobiology of Alzheimer's disease. Indian J. Psychiatr. 2009;51(1):55. doi: 10.4103/0019-5545.44908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Sanabria-Castro A., Alvarado-Echeverría I., Monge-Bonilla C. Molecular pathogenesis of Alzheimer's disease: an update. Ann. Neurosci. 2017;24(1):46–54. doi: 10.1159/000464422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Rai S.N., Tiwari N., Singh P., Singh A.K., Mishra D., Imran M., et al. Exploring the paradox of COVID-19 in neurological complications with emphasis on Parkinson’s and Alzheimer’s disease. Oxid. Med. Cell. Longev. 2022:2022. doi: 10.1155/2022/3012778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Benny A., Thomas J. Essential oils as treatment strategy for Alzheimerʼs disease: current and future perspectives. Planta Med. 2019;85(3):239–248. doi: 10.1055/a-0758-0188. [DOI] [PubMed] [Google Scholar]
  • 24.Srivastava P., Tripathi P.N., Sharma P., Rai S.N., Singh S.P., Srivastava R.K., et al. Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory. Eur. J. Med. Chem. 2019;163:116–135. doi: 10.1016/j.ejmech.2018.11.049. [DOI] [PubMed] [Google Scholar]
  • 25.Tripathi P.N., Srivastava P., Sharma P., Tripathi M.K., Seth A., Tripathi A., et al. Biphenyl-3-oxo-1, 2, 4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory. Bioorg. Chem. 2019;85:82–96. doi: 10.1016/j.bioorg.2018.12.017. [DOI] [PubMed] [Google Scholar]
  • 26.Rai S.N., Tiwari N., Singh P., Mishra D., Singh A.K., Hooshmandi E., et al. Therapeutic potential of vital transcription factors in Alzheimer’s and Parkinson’s disease with particular emphasis on transcription factor EB mediated autophagy. Front. Neurosci. 2021;15 doi: 10.3389/fnins.2021.777347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Singh A.K., Rai S.N., Maurya A., Mishra G., Awasthi R., Shakya A., et al. Therapeutic potential of phytoconstituents in management of Alzheimer’s disease. Evid. base Compl. Alternative Med. 2021;2021:1–19. doi: 10.1155/2021/5578574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ayaz M., Junaid M., Ahmed J., Ullah F., Sadiq A., Ahmad S., et al. Phenolic contents, antioxidant and anticholinesterase potentials of crude extract, subsequent fractions and crude saponins from Polygonum hydropiper L. BMC Compl. Alternative Med. 2014;14(1):145. doi: 10.1186/1472-6882-14-145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Engel J., Pedley T.A., Aicardi J. 2008. Epilepsy: a Comprehensive Textbook: Lippincott Williams & Wilkins. [Google Scholar]
  • 30.Kamal Z., Ullah F., Ayaz M., Sadiq A., Ahmad S., Zeb A., et al. Anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer’s and other neurological disorders. Biol. Res. 2015;48(1):21. doi: 10.1186/s40659-015-0011-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Hong-Qi Y., Zhi-Kun S., Sheng-Di C. Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau. Transl. Neurodegener. 2012;1(1):1–12. doi: 10.1186/2047-9158-1-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Alcolea-Palafox M., Posada-Moreno P., Ortuño-Soriano I., Pacheco-del-Cerro J.L., Martínez-Rincón C., Rodríguez-Martínez D., et al. 2014. Research Strategies Developed for the Treatment of Alzheimer’s Disease. Reversible and Pseudo-irreversible Inhibitors of Acetylcholinesterase: Structure-Activity Relationships and Drug Design; pp. 426–477. Drug Design and Discovery in Alzheimer's Disease: Elsevier. [Google Scholar]
  • 33.Ali B., Al-Wabel N.A., Shams S., Ahamad A., Khan S.A., Anwar F. Essential oils used in aromatherapy: a systemic review. Asian Pac. J. Trop. Biomed. 2015;5(8):601–611. [Google Scholar]
  • 34.Fotiou D., Kaltsatou A., Tsiptsios D., Nakou M. Evaluation of the cholinergic hypothesis in Alzheimer’s disease with neuropsychological methods. Aging Clin. Exp. Res. 2015;27(5):727–733. doi: 10.1007/s40520-015-0321-8. [DOI] [PubMed] [Google Scholar]
  • 35.Craig L.A., Hong N.S., McDonald R.J. Revisiting the cholinergic hypothesis in the development of Alzheimer's disease. Neurosci. Biobehav. Rev. 2011;35(6):1397–1409. doi: 10.1016/j.neubiorev.2011.03.001. [DOI] [PubMed] [Google Scholar]
  • 36.Zhao Y., Zhao B. vol. 2013. 2013. Oxidative Stress and the Pathogenesis of Alzheimer's Disease. Oxidative Medicine and Cellular Longevity. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Brahmachari G. Alpha Science International; Oxford: 2013. Role of Natural Products as a Source of Alzheimer’s Drug Leads: an Update. Natural Bioactive Molecules: Impacts & Prospects. [Google Scholar]
  • 38.Lin PWk, Chan Wc, Ng BFl, Lam LCw. Efficacy of aromatherapy (Lavandula angustifolia) as an intervention for agitated behaviours in Chinese older persons with dementia: a cross‐over randomized trial. Int. J. Geriatr. Psychiatr.: J. Psychiat. Late Life Allied Sci. 2007;22(5):405–410. doi: 10.1002/gps.1688. [DOI] [PubMed] [Google Scholar]
  • 39.Hancianu M., Cioanca O., Mihasan M., Hritcu L. Neuroprotective effects of inhaled lavender oil on scopolamine-induced dementia via anti-oxidative activities in rats. Phytomedicine. 2013;20(5):446–452. doi: 10.1016/j.phymed.2012.12.005. [DOI] [PubMed] [Google Scholar]
  • 40.Faixova Z., Faix S. Biological effects of rosemary (Rosmarinus officinalis L.) essential oil (a review) Folia Vet. 2008;52(3–4):135–139. [Google Scholar]
  • 41.Hongratanaworakit T. Simultaneous aromatherapy massage with rosemary oil on humans. Sci. Pharm. 2009;77(2):375–388. [Google Scholar]
  • 42.Mimica-Dukic N., Bozin B., Sokovic M., Simin N. Antimicrobial and antioxidant activities of Melissa officinalis L.(Lamiaceae) essential oil. J. Agric. Food Chem. 2004;52(9):2485–2489. doi: 10.1021/jf030698a. [DOI] [PubMed] [Google Scholar]
  • 43.Azizi Z., Ebrahimi S., Saadatfar E., Kamalinejad M., Majlessi N. Cognitive-enhancing activity of thymol and carvacrol in two rat models of dementia. Behav. Pharmacol. 2012;23(3):241–249. doi: 10.1097/FBP.0b013e3283534301. [DOI] [PubMed] [Google Scholar]
  • 44.Aazza S., Lyoussi B., Miguel M.G. Antioxidant and antiacetylcholinesterase activities of some commercial essential oils and their major compounds. Molecules. 2011;16(9):7672–7690. doi: 10.3390/molecules16097672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Bandelow B., Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin. Neurosci. 2015;17(3):327. doi: 10.31887/DCNS.2015.17.3/bbandelow. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Andrews G., Bell C., Boyce P., Gale C., Lampe L., Marwat O., et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Aust. N. Z. J. Psychiatr. 2018;52(12):1109–1172. [Google Scholar]
  • 47.Lowe N.K., Corwin E.J. Proposed biological linkages between obesity, stress, and inefficient uterine contractility during labor in humans. Med. Hypotheses. 2011;76(5):755–760. doi: 10.1016/j.mehy.2011.02.018. [DOI] [PubMed] [Google Scholar]
  • 48.Sadock B.J., Sadock V.A. 2011. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences/clinical Psychiatry: Lippincott Williams & Wilkins. [Google Scholar]
  • 49.Lee Y.-L., Wu Y., Tsang H.W., Leung A.Y., Cheung W. A systematic review on the anxiolytic effects of aromatherapy in people with anxiety symptoms. J. Alternative Compl. Med. 2011;17(2):101–108. doi: 10.1089/acm.2009.0277. [DOI] [PubMed] [Google Scholar]
  • 50.Sartori S.B., Singewald N. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacol. Ther. 2019;204 doi: 10.1016/j.pharmthera.2019.107402. [DOI] [PubMed] [Google Scholar]
  • 51.Toda M., Morimoto K. Effect of lavender aroma on salivary endocrinological stress markers. Arch. Oral Biol. 2008;53(10):964–968. doi: 10.1016/j.archoralbio.2008.04.002. [DOI] [PubMed] [Google Scholar]
  • 52.Kariuki-Nyuthe C., Stein D.J. Anxiety and related disorders and physical illness. Comorbidity Mental Phys. Disorders. 2015;179:81–87. [Google Scholar]
  • 53.Franco L., Blanck T.J., Dugan K., Kline R., Shanmugam G., Galotti A., et al. Both lavender fleur oil and unscented oil aromatherapy reduce preoperative anxiety in breast surgery patients: a randomized trial. J. Clin. Anesth. 2016;33:243–249. doi: 10.1016/j.jclinane.2016.02.032. [DOI] [PubMed] [Google Scholar]
  • 54.Kang H.-J., Nam E.S., Lee Y., Kim M. How strong is the evidence for the anxiolytic efficacy of lavender?: systematic review and meta-analysis of randomized controlled trials. Asian Nurs. Res. 2019;13(5):295–305. doi: 10.1016/j.anr.2019.11.003. [DOI] [PubMed] [Google Scholar]
  • 55.Kar S.K., Sarkar S. Neuro-stimulation techniques for the management of anxiety disorders: an update. Clinical Psychopharmacol. Neurosci. 2016;14(4):330. doi: 10.9758/cpn.2016.14.4.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Lebois L.A., Seligowski A.V., Wolff J.D., Hill S.B., Ressler K.J. Augmentation of extinction and inhibitory learning in anxiety and trauma-related disorders. Annu. Rev. Clin. Psychol. 2019;15:257–284. doi: 10.1146/annurev-clinpsy-050718-095634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Kaplan H.I., Sadock B.J., Grebb J.A. 1994. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences, Clinical Psychiatry: Williams & Wilkins Co. [Google Scholar]
  • 58.Hoehn-Saric R. Neurotransmitters in anxiety. Arch. Gen. Psychiatr. 1982;39(6):735–742. doi: 10.1001/archpsyc.1982.04290060075015. [DOI] [PubMed] [Google Scholar]
  • 59.Alireza K., Nasrin H.-F., Mina R., Zahra A., Siamak S., Abdolrahman S. Study the anti-anxiety effect of acute injection of lavandula angustifolia extract in elevated plus-maze test in male rat. Int. J. Pharmacognosy Phytochemical Res. 2014;6(4):879–882. [Google Scholar]
  • 60.Fernandez M., Ferrer M., Flores K., Florido A., Foronda K. The effect of lavender aromatherapy to junior nursing students’ anxiety, concentration and memory retention. Int Arch Nurs Health Care: IANHC-102. 2018;7 [Google Scholar]
  • 61.Tabatabaeichehr M., Mortazavi H. The effectiveness of aromatherapy in the management of labor pain and anxiety: a systematic review. Ethiopian J. Health Sci. 2020;30(3) doi: 10.4314/ejhs.v30i3.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Kasper S., Gastpar M., Müller W.E., Volz H.-P., Möller H.-J., Dienel A., et al. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’anxiety disorder: a randomized, double-blind, placebo controlled trial. Int. Clin. Psychopharmacol. 2010;25(5):277–287. doi: 10.1097/YIC.0b013e32833b3242. [DOI] [PubMed] [Google Scholar]
  • 63.Chioca L.R., Ferro M.M., Baretta I.P., Oliveira S.M., Silva C.R., Ferreira J., et al. Anxiolytic-like effect of lavender essential oil inhalation in mice: participation of serotonergic but not GABAA/benzodiazepine neurotransmission. J. Ethnopharmacol. 2013;147(2):412–418. doi: 10.1016/j.jep.2013.03.028. [DOI] [PubMed] [Google Scholar]
  • 64.Schuwald A.M., Nöldner M., Wilmes T., Klugbauer N., Leuner K., Müller W.E. Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels. PLoS One. 2013;8(4) doi: 10.1371/journal.pone.0059998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Motomura N., Sakurai A., Yotsuya Y. Reduction of mental stress with lavender odorant. Percept. Mot. Skills. 2001;93(3):713–718. doi: 10.2466/pms.2001.93.3.713. [DOI] [PubMed] [Google Scholar]
  • 66.Huang L., Abuhamdah S., Howes M.J.R., Dixon C.L., Elliot M.S., Ballard C., et al. Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti‐agitation properties: focus on ligand‐gated channels. J. Pharm. Pharmacol. 2008;60(11):1515–1522. doi: 10.1211/jpp/60.11.0013. [DOI] [PubMed] [Google Scholar]
  • 67.Aprotosoaie A.C., Hăncianu M., Costache, Miron A. Linalool: a review on a key odorant molecule with valuable biological properties. Flavour Fragrance J. 2014;29(4):193–219. [Google Scholar]
  • 68.Baldinger P., Höflich A.S., Mitterhauser M., Hahn A., Rami-Mark C., Spies M., et al. Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging. Int. J. Neuropsychopharmacol. 2015;18(4) doi: 10.1093/ijnp/pyu063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Zamanifar S., Bagheri-Saveh M.I., Nezakati A., Mohammadi R., Seidi J. The effect of music therapy and aromatherapy with chamomile-lavender essential oil on the anxiety of clinical nurses: a randomized and double-blind clinical trial. J. Med. Life. 2020;13(1):87. doi: 10.25122/jml-2019-0105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Karimzadeh Z., Azizzadeh Forouzi M., Rahiminezhad E., Ahmadinejad M., Dehghan M. The effects of lavender and citrus aurantium on anxiety and agitation of the conscious patients in intensive care units: a parallel randomized placebo-controlled trial. BioMed Res. Int. 2021;2021:1–8. doi: 10.1155/2021/5565956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Ebrahimi H., Mardani A., Basirinezhad M.H., Hamidzadeh A., Eskandari F. The effects of Lavender and Chamomile essential oil inhalation aromatherapy on depression, anxiety and stress in older community-dwelling people: a randomized controlled trial. Explore. 2022;18(3):272–278. doi: 10.1016/j.explore.2020.12.012. [DOI] [PubMed] [Google Scholar]
  • 72.Moghadam Z.E., Delmoradi F., Aemmi S.Z., Vaghee S., Vashani H.B. Effectiveness of aromatherapy with inhaled lavender essential oil and breathing exercises on ECT-related anxiety in depressed patients. Explore. 2022;18(6):683–687. doi: 10.1016/j.explore.2021.12.006. [DOI] [PubMed] [Google Scholar]
  • 73.Smith K., De Torres I. A world of depression. Nature. 2014;515 doi: 10.1038/515180a. [DOI] [PubMed] [Google Scholar]
  • 74.Nerli R., Ghagane S.C., Dixit N.S. World suicide prevention day. Indian J. Health Sci. Biomed. Res. (KLEU) 2018;11(3):189. [Google Scholar]
  • 75.Brent D.A., Kolko D.J., Birmaher B., Baugher M., Bridge J., Roth C., et al. Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. J. Am. Acad. Child Adolesc. Psychiatry. 1998;37(9):906–914. doi: 10.1097/00004583-199809000-00010. [DOI] [PubMed] [Google Scholar]
  • 76.First M.B. 1994. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV: American Psychiatric Publishing. [Google Scholar]
  • 77.Micheli L., Ceccarelli M., D’Andrea G., Tirone F. Depression and adult neurogenesis: positive effects of the antidepressant fluoxetine and of physical exercise. Brain Res. Bull. 2018;143:181–193. doi: 10.1016/j.brainresbull.2018.09.002. [DOI] [PubMed] [Google Scholar]
  • 78.Beck D.A., Koenig H.G., Beck J.S. Depression. Clin. Geriatr. Med. 1998;14(4):765–786. [PubMed] [Google Scholar]
  • 79.Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. Am. J. Psychiatr. 2006;163(11):1905–1917. doi: 10.1176/ajp.2006.163.11.1905. [DOI] [PubMed] [Google Scholar]
  • 80.Rimer J., Dwan K., Lawlor D., Greig C., McMurdo M., Morley W., et al. 2012. Exercise for Depression, the Cochrane Database of Systematic Reviews; p. CD004366. [Abstract][Google Scholar] [DOI] [PubMed] [Google Scholar]
  • 81.Xiong M., Li Y., Tang P., Zhang Y., Cao M., Ni J., et al. Effectiveness of aromatherapy massage and inhalation on symptoms of depression in Chinese community-dwelling older adults. J. Alternative Compl. Med. 2018;24(7):717–724. doi: 10.1089/acm.2017.0320. [DOI] [PubMed] [Google Scholar]
  • 82.Beekman A.T., Penninx B.W., Deeg D.J., Beurs Ed, Geerlings S.W., Wv Tilburg. The impact of depression on the well‐being, disability and use of services in older adults: a longitudinal perspective. Acta Psychiatr. Scand. 2002;105(1):20–27. doi: 10.1034/j.1600-0447.2002.10078.x. [DOI] [PubMed] [Google Scholar]
  • 83.Freeman M.P. Complementary and alternative medicine for perinatal depression. J. Affect. Disord. 2009;112(1–3):1–10. doi: 10.1016/j.jad.2008.06.017. [DOI] [PubMed] [Google Scholar]
  • 84.Butler A.C., Chapman J.E., Forman E.M., Beck A.T. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin. Psychol. Rev. 2006;26(1):17–31. doi: 10.1016/j.cpr.2005.07.003. [DOI] [PubMed] [Google Scholar]
  • 85.Cuijpers P., Geraedts A.S., van Oppen P., Andersson G., Markowitz J.C., van Straten A. Interpersonal psychotherapy for depression: a meta-analysis. Am. J. Psychiatr. 2011;168(6):581–592. doi: 10.1176/appi.ajp.2010.10101411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Buckle J. Clinical Aromatherapy: Essential oils in Practice 63. Arnold. Churchill Livingstone; 2003. pp. 76–77. [Google Scholar]
  • 87.Dobetsberger C., Buchbauer G. Actions of essential oils on the central nervous system: an updated review. Flavour Fragrance J. 2011;26(5):300–316. [Google Scholar]
  • 88.López V., Nielsen B., Solas M., Ramírez M.J., Jäger A.K. Exploring pharmacological mechanisms of lavender (Lavandula angustifolia) essential oil on central nervous system targets. Front. Pharmacol. 2017;8:280. doi: 10.3389/fphar.2017.00280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Armstrong F., Heidingsfeld V. Aromatherapy for deaf and deafblind people living in residential accommodation. Compl. Ther. Nurs. Midwifery. 2000;6(4):180–188. doi: 10.1054/ctnm.2000.0488. [DOI] [PubMed] [Google Scholar]
  • 90.Yim V., Ng A.K., Tsang H.W., Leung A.Y. A review on the effects of aromatherapy for patients with depressive symptoms. J. Alternative Compl. Med. 2009;15(2):187–195. doi: 10.1089/acm.2008.0333. [DOI] [PubMed] [Google Scholar]
  • 91.Tang S.K., Tse M. Aromatherapy: does it help to relieve pain, depression, anxiety, and stress in community-dwelling older persons? BioMed Res. Int. 2014;2014 doi: 10.1155/2014/430195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Da Porto C., Decorti D., Kikic I. Flavour compounds of Lavandula angustifolia L. to use in food manufacturing: comparison of three different extraction methods. Food Chem. 2009;112(4):1072–1078. [Google Scholar]
  • 93.Cline M., Taylor J.E., Flores J., Bracken S., McCall S., Ceremuga T.E. Investigation of the anxiolytic effects of linalool, a lavender extract, in the male Sprague-Dawley rat. AANA J. 2008;76(1) [PubMed] [Google Scholar]
  • 94.Linck V.M., da Silva A.L., Figueiro M., Caramao E.B., Moreno P.R.H., Elisabetsky E. Effects of inhaled Linalool in anxiety, social interaction and aggressive behavior in mice. Phytomedicine. 2010;17(8–9):679–683. doi: 10.1016/j.phymed.2009.10.002. [DOI] [PubMed] [Google Scholar]
  • 95.Elisabetsky E., Marschner J., Souza D.O. Effects of linalool on glutamatergic system in the rat cerebral cortex. Neurochem. Res. 1995;20(4):461–465. doi: 10.1007/BF00973103. [DOI] [PubMed] [Google Scholar]
  • 96.Brum L.S., Emanuelli T., Souza D., Elisabetsky E. Effects of linalool on glutamate release and uptake in mouse cortical synaptosomes. Neurochem. Res. 2001;26(3):191–194. doi: 10.1023/a:1010904214482. [DOI] [PubMed] [Google Scholar]
  • 97.de Almeida A.A.C., Costa J.P., de Carvalho R.B.F., de Sousa D.P., de Freitas R.M. Evaluation of acute toxicity of a natural compound (+)-limonene epoxide and its anxiolytic-like action. Brain Res. 2012;1448:56–62. doi: 10.1016/j.brainres.2012.01.070. [DOI] [PubMed] [Google Scholar]
  • 98.Cavanagh Htt, Wilkinson Jt. Biological activities of lavender essential oil. Phytother Res. 2002;16(4):301–308. doi: 10.1002/ptr.1103. [DOI] [PubMed] [Google Scholar]
  • 99.Araj-Khodaei M., Noorbala A.A., Yarani R., Emadi F., Emaratkar E., Faghihzadeh S., et al. A double-blind, randomized pilot study for comparison of Melissa officinalis L. and Lavandula angustifolia Mill. with Fluoxetine for the treatment of depression. BMC Complement. Med. Therapies. 2020;20(1):1–9. doi: 10.1186/s12906-020-03003-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Bakhtshirin F., Abedi S., YusefiZoj P., Razmjooee D. The effect of aromatherapy massage with lavender oil on severity of primary dysmenorrhea in Arsanjan students. Iran. J. Nurs. Midwifery Res. 2015;20(1):156. [PMC free article] [PubMed] [Google Scholar]
  • 101.Peana A.T., Moretti M.D., Watson R., Preedy V. Linalool in essential plant oils: pharmacological effects. Botanical Med. Clinical Pract. 2008;10(55):716–724. [Google Scholar]
  • 102.Fißler M., Quante A. A case series on the use of lavendula oil capsules in patients suffering from major depressive disorder and symptoms of psychomotor agitation, insomnia and anxiety. Compl. Ther. Med. 2014;22(1):63–69. doi: 10.1016/j.ctim.2013.11.008. [DOI] [PubMed] [Google Scholar]
  • 103.Bakhsha F., Mazandarani M., Aryaei M., Jafari S.Y. 2014. Phytochemical and Anti-oxidant Activity of Lavandula Angustifolia Mill. Essential Oil on Preoperative Anxiety in Patients Undergoing Diagnostic Curettage. [Google Scholar]
  • 104.Igarashi T. Physical and psychologic effects of aromatherapy inhalation on pregnant women: a randomized controlled trial. J. Alternative Compl. Med. 2013;19(10):805–810. doi: 10.1089/acm.2012.0103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Effati-Daryani F., Mohammad-Alizadeh-Charandabi S., Mirghafourvand M., Taghizadeh M., Mohammadi A. Effect of lavender cream with or without foot-bath on anxiety, stress and depression in pregnancy: a randomized placebo-controlled trial. J. Caring Sci. 2015;4(1):63. doi: 10.5681/jcs.2015.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Tayebi A., Kasra Dehkordi A., Ebadi A., Sahraei H., Einollahi B. The effect of aromatherapy with lavender essential oil on depression, anxiety and stress in hemodialysis patients: a clinical trial. Evidence Based Care. 2015;5(2):65–74. [Google Scholar]
  • 107.Jokar M., Delam H., Bakhtiari S., Paki S., Askari A., Bazrafshan M.-R., et al. The effects of inhalation lavender aromatherapy on postmenopausal women’s depression and anxiety: a randomized clinical trial. J. Nurse Pract. 2020;16(8):617–622. [Google Scholar]
  • 108.Bazrafshan M.-R., Jokar M., Shokrpour N., Delam H. The effect of lavender herbal tea on the anxiety and depression of the elderly: a randomized clinical trial. Compl. Ther. Med. 2020;50 doi: 10.1016/j.ctim.2020.102393. [DOI] [PubMed] [Google Scholar]
  • 109.Firoozeei T.S., Barekatain M., Karimi M., Zargaran A., Akhondzadeh S., Rezaeizadeh H. Lavender and dodder combined herbal syrup versus citalopram in major depressive disorder with anxious distress: a double-blind randomized trial. J. Integrat. Med. 2020;18(5):409–415. doi: 10.1016/j.joim.2020.06.002. [DOI] [PubMed] [Google Scholar]
  • 110.Kwan P., Brodie M.J. Early identification of refractory epilepsy. N. Engl. J. Med. 2000;342(5):314–319. doi: 10.1056/NEJM200002033420503. [DOI] [PubMed] [Google Scholar]
  • 111.Kwan P., Arzimanoglou A., Berg A.T., Brodie M.J., Allen Hauser W., Mathern G., et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069–1077. doi: 10.1111/j.1528-1167.2009.02397.x. [DOI] [PubMed] [Google Scholar]
  • 112.Schmidt D. Drug treatment of epilepsy: options and limitations. Epilepsy Behav. 2009;15(1):56–65. doi: 10.1016/j.yebeh.2009.02.030. [DOI] [PubMed] [Google Scholar]
  • 113.Shorvon S.D. 2000. Handbook of Epilepsy Treatment: Citeseer. [Google Scholar]
  • 114.Rogawski M.A. Principles of antiepileptic drug action. Antiepileptic drugs. 2002;5 [Google Scholar]
  • 115.Lehnertz K., Le Van Quyen M., Litt B., Engel J., Pedley T. 2007. Epilepsy: a Comprehensive Textbook. Lippincott Williams & Wilkins Philadelphia. [Google Scholar]
  • 116.Engel J., Jr. Quality standards subcommittee of the American academy of neurology; American epilepsy society; American association of neurological surgeons. Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the quality standards subcommittee of the American academy of neurology, in association with the American epilepsy society and the American association of neurological surgeons. Neurology. 2003;60:538–547. doi: 10.1212/01.wnl.0000055086.35806.2d. [DOI] [PubMed] [Google Scholar]
  • 117.Choi H., Sell R.L., Lenert L., Muennig P., Goodman R.R., Gilliam F.G., et al. Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis. JAMA. 2008;300(21):2497–2505. doi: 10.1001/jama.2008.771. [DOI] [PubMed] [Google Scholar]
  • 118.Boon P., Raedt R., De Herdt V., Wyckhuys T., Vonck K. Electrical stimulation for the treatment of epilepsy. Neurotherapeutics. 2009;6(2):218–227. doi: 10.1016/j.nurt.2008.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Ekstein D., Schachter S.C. Natural products in epilepsy—the present situation and perspectives for the future. Pharmaceuticals. 2010;3(5):1426–1445. doi: 10.3390/ph3051426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Bahr T.A., Rodriguez D., Beaumont C., Allred K. The effects of various essential oils on epilepsy and acute seizure: a systematic review. Evid. base Compl. Alternative Med. 2019;2019 doi: 10.1155/2019/6216745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Milanos S., Elsharif S.A., Janzen D., Buettner A., Villmann C. Metabolic products of linalool and modulation of GABAA receptors. Front. Chem. 2017;5:46. doi: 10.3389/fchem.2017.00046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Souto-Maior F.N., Fonsêca DVd, Salgado P.R.R., Monte LdO., de Sousa D.P., de Almeida R.N. Antinociceptive and anticonvulsant effects of the monoterpene linalool oxide. Pharmaceut. Biol. 2017;55(1):63–67. doi: 10.1080/13880209.2016.1228682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Vatanparast J., Bazleh S., Janahmadi M. The effects of linalool on the excitability of central neurons of snail Caucasotachea atrolabiata. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2017;192:33–39. doi: 10.1016/j.cbpc.2016.12.004. [DOI] [PubMed] [Google Scholar]
  • 124.Rakotosaona R., Randrianarivo E., Rasoanaivo P., Nicoletti M., Benelli G., Maggi F. Effect of the leaf essential oil from Cinnamosma madagascariensis Danguy on pentylenetetrazol‐induced seizure in rats. Chem. Biodivers. 2017;14(10) doi: 10.1002/cbdv.201700256. [DOI] [PubMed] [Google Scholar]
  • 125.Azanchi T., Shafaroodi H., Asgarpanah J. Anticonvulsant activity of Citrus aurantium blossom essential oil (neroli): involvment of the GABAergic system. Nat. Prod. Commun. 2014;9(11):1615. [PubMed] [Google Scholar]
  • 126.Mandegary A., Sharififar F., Abdar M., Arab-Nozari M. Anticonvulsant activity and toxicity of essential oil and methanolic extract of Zhumeria majdae Rech, a unique Iranian plant in mice. Neurochem. Res. 2012;37(12):2725–2730. doi: 10.1007/s11064-012-0863-5. [DOI] [PubMed] [Google Scholar]
  • 127.Yamada K., Mimaki Y., Sashida Y. Anticonvulsive effects of inhaling lavender oil vapour. Biol. Pharm. Bull. 1994;17(2):359–360. doi: 10.1248/bpb.17.359. [DOI] [PubMed] [Google Scholar]
  • 128.Stewart W., Shechter A., Rasmussen B. Migraine prevalence: a review of population-based studies. Neurology. 1994;44(6) [PubMed] [Google Scholar]
  • 129.Goadsby P.J., Holland P.R., Martins-Oliveira M., Hoffmann J., Schankin C., Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol. Rev. 2017;97(2):553–622. doi: 10.1152/physrev.00034.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Noseda R., Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. PAIN®. 2013;154:S44–S53. doi: 10.1016/j.pain.2013.07.021. [DOI] [PubMed] [Google Scholar]
  • 131.Kunkler P.E., Zhang L., Johnson P.L., Oxford G.S., Hurley J.H. Induction of chronic migraine phenotypes in a rat model after environmental irritant exposure. Pain. 2018;159(3):540. doi: 10.1097/j.pain.0000000000001124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Vickers N.J. Animal communication: when i’m calling you, will you answer too? Curr. Biol. 2017;27(14):R713–R715. doi: 10.1016/j.cub.2017.05.064. [DOI] [PubMed] [Google Scholar]
  • 133.Le P., Vu T.T., Davis R.M. 2020. Investigating the Strength and Presence of Medical Associations with Big Data Discovery Technology in a Retrospective Case-Control Study Design: an Analysis of Dry Eye Disease and Migraine Headaches. SAGE Publications Ltd. [Google Scholar]
  • 134.Todd C., Lagman-Bartolome A.M., Lay C. Women and migraine: the role of hormones. Curr. Neurol. Neurosci. Rep. 2018;18(7):42. doi: 10.1007/s11910-018-0845-3. [DOI] [PubMed] [Google Scholar]
  • 135.Eikermann-Haerter K., Dileköz E., Kudo C., Savitz S.I., Waeber C., Baum M.J., et al. Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J. Clin. Investig. 2009;119(1):99–109. doi: 10.1172/JCI36059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Fantasia H.C. Migraine headache prophylaxis in adolescents. Nursing Women's Health. 2014;18(5):420–424. doi: 10.1111/1751-486X.12150. [DOI] [PubMed] [Google Scholar]
  • 137.Chayasirisobhon S. Efficacy of Pinus radiata bark extract and vitamin C combination product as a prophylactic therapy for recalcitrant migraine and long-term results. Acta Neurol. Taiwan. 2013;22(1):13–21. [PubMed] [Google Scholar]
  • 138.D'amico D., Solari A., Usai S., Santoro P., Bernardoni P., Frediani F., et al. Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia. 2006;26(6):691–696. doi: 10.1111/j.1468-2982.2005.01094.x. [DOI] [PubMed] [Google Scholar]
  • 139.Lipton R.B., Scher A., Steiner T., Bigal M., Kolodner K., Liberman J., et al. Patterns of health care utilization for migraine in England and in the United States. Neurology. 2003;60(3):441–448. doi: 10.1212/wnl.60.3.441. [DOI] [PubMed] [Google Scholar]
  • 140.Rafie S., Namjoyan F., Golfakhrabadi F., Yousefbeyk F., Hassanzadeh A. Effect of lavender essential oil as a prophylactic therapy for migraine: a randomized controlled clinical trial. J. Herb. Med. 2016;6(1):18–23. [Google Scholar]
  • 141.Yuan R., Zhang D., Yang J., Wu Z., Luo C., Han L., et al. Review of aromatherapy essential oils and their mechanism of action against migraines. J. Ethnopharmacol. 2020 doi: 10.1016/j.jep.2020.113326. [DOI] [PubMed] [Google Scholar]
  • 142.Yiannakopoulou E. Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin. Pharmacology. 2015;95(1–2):65–69. doi: 10.1159/000370245. [DOI] [PubMed] [Google Scholar]
  • 143.Donatello N.N., Emer A.A., Salm D.C., Ludtke D.D., Bordignon S.A.S.R., Ferreira J.K., et al. Lavandula angustifolia essential oil inhalation reduces mechanical hyperalgesia in a model of inflammatory and neuropathic pain: the involvement of opioid and cannabinoid receptors. J. Neuroimmunol. 2020;340 doi: 10.1016/j.jneuroim.2020.577145. [DOI] [PubMed] [Google Scholar]
  • 144.Aboutaleb N., Jamali H., Abolhasani M., Toroudi H.P. Lavender oil (Lavandula angustifolia) attenuates renal ischemia/reperfusion injury in rats through suppression of inflammation, oxidative stress and apoptosis. Biomed. Pharmacother. 2019;110:9–19. doi: 10.1016/j.biopha.2018.11.045. [DOI] [PubMed] [Google Scholar]
  • 145.Dunn P., Ghadiri M., Gorji A. Lavender and the nervous system. Evid. base Compl. Alternative Med. 2013;2013:10. doi: 10.1155/2013/681304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146.Koto R., Imamura M., Watanabe C., Obayashi S., Shiraishi M., Sasaki Y., et al. Linalyl acetate as a major ingredient of lavender essential oil relaxes the rabbit vascular smooth muscle through dephosphorylation of myosin light chain. J. Cardiovasc. Pharmacol. 2006;48(1):850–856. doi: 10.1097/01.fjc.0000238589.00365.42. [DOI] [PubMed] [Google Scholar]
  • 147.Shin Y.K., Hsieh Y.S., Kwon S., Lee H.S., Seol G.H. Linalyl acetate restores endothelial dysfunction and hemodynamic alterations in diabetic rats exposed to chronic immobilization stress. J. Appl. Physiol. 2018;124(5):1274–1283. doi: 10.1152/japplphysiol.01018.2017. [DOI] [PubMed] [Google Scholar]
  • 148.Chen S.-J., Chen C.-H., Chang H.-Y. Effects of inhaling essential oil on headache-related quality of life among nurses working in emergency and critical care units. Hu Li Za Zhi. 2021;68(5):51–64. doi: 10.6224/JN.202110_68(5).08. [DOI] [PubMed] [Google Scholar]
  • 149.Koulivand P.H., Khaleghi Ghadiri M., Gorji A. vol. 2013. 2013. Lavender and the Nervous System. Evidence-Based Complementary and Alternative Medicine. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150.Fella C., Amina D., Latifa A., Narimene L., Chahira R., Chaima S., et al. The effects of lavender essential oil and gallic acid pre-treatment on the neurocognitive assessment of post-stroke wistar rats. Uttar Pradesh J. Zool. 2022;43(12):37–47. [Google Scholar]
  • 151.Cavanagh H., Wilkinson J. Biological activities of lavender essential oil. Phytother Res. 2002;16(4):301–308. doi: 10.1002/ptr.1103. [DOI] [PubMed] [Google Scholar]
  • 152.Jager W. Percutaneous absorption of lavender oil from massage oil. J. Soc. Cosmet. Chem. 1992;43:49–54. [Google Scholar]
  • 153.Woronuk G., Demissie Z., Rheault M., Mahmoud S. Biosynthesis and therapeutic properties of Lavandula essential oil constituents. Planta Med. 2011;77(1):7–15. doi: 10.1055/s-0030-1250136. [DOI] [PubMed] [Google Scholar]
  • 154.Perry R., Terry R., Watson L., Ernst E. Is lavender an anxiolytic drug? A systematic review of randomised clinical trials. Phytomedicine. 2012;19(8–9):825–835. doi: 10.1016/j.phymed.2012.02.013. [DOI] [PubMed] [Google Scholar]
  • 155.Akhondzadeh S., Kashani L., Fotouhi A., Jarvandi S., Mobaseri M., Moin M., et al. Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial. Prog. Neuro Psychopharmacol. Biol. Psychiatr. 2003;27(1):123–127. doi: 10.1016/s0278-5846(02)00342-1. [DOI] [PubMed] [Google Scholar]
  • 156.Dwyer A.V., Whitten D.L., Hawrelak J.A. Herbal medicines, other than St. John's Wort, in the treatment of depression: a systematic review. Alternative Med. Rev. 2011;16(1) [PubMed] [Google Scholar]
  • 157.Gilani A., Aziz N., Khan M., Shaheen F., Jabeen Q., Siddiqui B., et al. Ethnopharmacological evaluation of the anticonvulsant, sedative and antispasmodic activities of Lavandula stoechas L. J. Ethnopharmacol. 2000;71(1–2):161–167. doi: 10.1016/s0378-8741(99)00198-1. [DOI] [PubMed] [Google Scholar]
  • 158.Umezu T. Behavioral effects of plant-derived essential oils in the Geller type conflict test in mice. Jpn. J. Pharmacol. 2000;83(2):150–153. doi: 10.1254/jjp.83.150. [DOI] [PubMed] [Google Scholar]

Articles from Heliyon are provided here courtesy of Elsevier

RESOURCES